CD11b inhibition promoted macrophage polarization toward an anti-inflammatory (M2) state and accelerated tumor growth, while the activation of CD11b shifted polarization toward pro-inflammatory M1 macrophages, favoring tumor suppression in animal models of murine and human cancers. Here, ITGAM is linked to cancer.